EAM Investors, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$2,395,000
-46.5%
68,855
-44.8%
0.58%
-29.9%
Q1 2022$4,477,000
+84.0%
124,697
+2.0%
0.83%
+26.2%
Q4 2018$2,433,000
-23.7%
122,250
-29.3%
0.66%
+55.9%
Q4 2016$3,187,000
-13.1%
173,018
-10.5%
0.42%
-14.0%
Q3 2016$3,668,000
-7.8%
193,355
-21.7%
0.49%
-17.6%
Q2 2016$3,978,000
+231.8%
246,805
+261.8%
0.60%
+327.1%
Q2 2015$1,199,00068,2240.14%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders